SNCA and synucleinopathy: On the flip side, overexpression of VPS35 has been found to be protective against the accumulation and aggregation of alpha-synuclein observed in a synucleinopathy transgenic mouse model as well as in an alpha-synuclein prion-like seeding mouse model [38].